Companies / Crescent Biopharma, Inc. / Activity
Activity — Crescent Biopharma, Inc.
6 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2025 as of | Boxer Capital Management, LLC 13F manager | New | Common stock | $7.32M | +454K | 453,686 1.22% of shares | medium |
| Q2 2026 as of | Remedium Capital Partners, LLC 13F manager | New | Common stock | $6.50M | +361K | 361,250 0.97% of shares | medium |
| Q1 2026 as of | Hudson Bay Capital Management LP 13F manager | New | Common stock | $1.63M | +89K | 88,867 0.24% of shares | low |
| Q2 2026 as of | Persistent Asset Partners Ltd 13F manager | New | Common stock | $197.4K | +11K | 10,968 0.03% of shares | low |
| Q2 2025 as of | Barclays PLC 13F manager | New | Common stock | $4.6K | +286 | 286 <0.01% of shares | low |
| Q1 2026 as of | Algert Global LLC 13F manager | New | Common stock | $254 | +14K | 13,806 0.04% of shares | low |